Dreher - Figure 33
Retrospective Study: Galli et al
This Figure shows the results of a retrospective analysis of home NIV use following acute respiratory failure in COPD.[17] The blue line is percent survival in the group receiving HMV, the red line is percent survival in the group not receiving HMV. It is clear that the patients receiving HMV after acute hypercapnic respiratory failure due to COPD have better long-term survival compared to the group not receiving HMV.
Dreher M. Chest 2017:00.
References
[17]
Galli JA, Krahnke JS, Mamary AJ, et al. Home non-invasive ventilation use following acute hypercapnic respiratory failure in COPD. Respir Med. 2014;108:722−8. doi: 10.1016/j.rmed.2014.03.006.